MedTrace Logo

Quality of Life After Transcatheter Aortic Valve Implantation

NCT07798713 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-09-01

No results posted yet for this study

Summary

This observational cohort study investigates whether hemodynamic improvements following transcatheter aortic valve implantation (TAVI) are associated with improvements in patient-reported quality of life among patients in Western Denmark.

Quality of life will be assessed using the Kansas City Cardiomyopathy Questionnaire before TAVI and at follow-up. Changes in quality of life will be evaluated in relation to changes in mean transvalvular gradient, left ventricular ejection fraction, and New York Heart Association functional class. Clinical data will be obtained from patient records.

Secondary analyses will explore whether patient characteristics, comorbidities, anatomical factors, and procedural characteristics are associated with quality-of-life improvement following TAVI.

The study aims to improve understanding of the relationship between objective treatment outcomes and patients' perceived health status after TAVI.

Conditions

  • Aortic Stenosis
  • Heart Failure
  • Angina Pectoris
  • TAVI(Transcatheter Aortic Valve Implantation)

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Ashkan Eftekhari, MD PhD · Aalborg University Hospital Dept. of Cardiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-26
Primary Completion
2028-09-01
Completion
2029-01-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07798713 on ClinicalTrials.gov